CDMO Services
Scale up seamlessly with integrated RNA therapeutics CDMO solutions
Axolabs CDMO platform encompasses early-stage discovery to commercial GMP production. Working in concert with our CRO team, we ensure data-driven decisions and a smooth transition from discovery through to clinical development and commercial success.

Download services list
Axolabs CDMO platform encompasses early-stage discovery to commercial GMP production. Working in concert with our CRO team, we ensure data-driven decisions and a smooth transition from discovery through to clinical development and commercial success.
Early-stage synthesis & lead optimisation
We rapidly produce and optimise siRNAs, ASOs, aptamers, and sgRNAs in 96-well plate formats. On-resin and post-synthetic conjugation (e.g. GalNAc, peptides, lipids) enables precise modifications.
- Automated purification (AEX, RP, SEC) for consistent quality and deliverable amounts per well.
- Customisable supports for unique conjugations.


Large-scale chemical manufacturing
Using Cytiva's OligoPilot™ (pilot) and OligoProcess™ (commercial), alongside the Asahi Kasei Bioprocess (AKB) THESYS™ Synth100 (pilot) and Synth1500 (commercial) platforms in our newly operational Berlin facility, we scale from milligram to kilogram batches under QbD/DoE-driven optimisation.
- Scalable workflows for GLP-tox, clinical, and commercial needs.
- In-line process monitoring (UV, conductivity) ensures quality.


cGMP production
Our Petaluma (USA) and Berlin (Germany) sites offer numerous cGMP suites for a secure global supply. Production scales cover early-phase through commercial volumes using several redundant systems from two key equipment providers (Cytiva, Asahi Kasei).
- Petaluma: up to 300 mmol batch capacity.
- Berlin: commercial runs up to or more than 1500mmol per batch.


GMP analytics & quality control
We provide GMP-aligned analytical development, validation, and stability programmes, meeting EMA/FDA/ICH guidelines.
- High-resolution LC-MS/MS, uHPLC, FT-IR, and CE.
- ICH compliant release and stability analytics, forced degradation studies and real time data analyses for robust quality control.


Integrated technology transfer
Unified QA oversight and project management bridge discovery data with commercial-scale requirements, minimising rework.
- Centralised documentation accelerates validation.
- Smooth transition from early development to market launch.


Contact us
Find out morePartner with a global leader in oligonucleotide research, development, and manufacturing. Whether you need early-stage optimisation, large-scale GMP production, or specialised analytical support, Axolabs’ experts are ready to help. Get in touch to discuss your project, request a capabilities overview, or schedule a technical consultation.